News

Gary Lowenthal Joins Focused Ultrasound Foundation’s Council

The Focused Ultrasound Foundation is pleased to welcome Gary Lowenthal to its Council, a dedicated group of goodwill ambassadors who work closely with the Board of Directors and staff to provide advice and assist with raising funds and building awareness.

Mr. Lowenthal is a retired educator, entrepreneur, and executive with a career spanning education, international service, and business leadership.

He began his professional journey as a teacher serving in the Peace Corps, teaching in underserved communities in Fiji. Upon returning to the US, he held an executive position at Bloomingdale’s before founding The Boyds Collection Ltd. in 1979, a company that became a leader in the plush and figurine market renowned for its lovingly crafted handmade collectibles. As “the Head Bean Hisself,” he personally designed much of the original Boyds Bears lineup, infusing each piece with his sense of humor, warmth, and a clear eye for character.

In addition to his business ventures, Mr. Lowenthal remained dedicated to education and taught entrepreneurship to budding innovators at Mount St. Mary’s University.

“Gary’s unique blend of creativity, entrepreneurial spirit, and dedication to service makes him a tremendous asset to the Foundation’s Council,” said Foundation Chairman Neal F. Kassell, MD. “His insight and energy will strengthen our efforts to advance this transformative technology and expand its access to patients.”

“It’s an honor to join the Foundation’s Council and support such groundbreaking work,” Mr. Lowenthal said. “I’m inspired by the potential of focused ultrasound to revolutionize medicine, and I look forward to contributing to a mission that has real, lasting impact on people’s lives.”

Born and raised in New York City, Mr. Lowenthal earned a bachelor of science degree in biology and a master’s degree in biology and education from Alfred University.

Read more here.

Recent News

04/08/2026

Likarda and The Tiny Cargo Company Announce Strategic Partnership to Advance Next-Generation Delivery of Biologics, Peptides and Small Molecules

Likarda, Inc., a leader in hydrogel-based drug delivery technologies, today announced a strategic partnership with Tiny Cargo, an innovator in extracellular vesicle (EV) delivery systems. The collaboration will focus on advancing the delivery of biologics and small molecules by integrating Likarda’s Core-Shell Spherification® (CSS®) platform with Tiny Cargo’s vesicle-based technologies. The partnership is designed to

04/08/2026

ReAlta Life Sciences Closes Oversubscribed $40 Million Financing Round to Advance Pegtarazimod Phase 2 Program in Hypoxic Ischemic Encephalopathy (HIE)

ReAlta Life Sciences Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company focused on safely targeting neutrophils and central components of the complement system to potentially revolutionize the treatment of inflammatory disorders, today announced the closing of an oversubscribed $40 million financing. This brings the total capital raised to date to more than $150 million.

04/02/2026

ATCC Receives New CDC Award to Help Fast-track Diagnostic Tests for Future Disease Outbreaks

TCC has been selected by the Centers for Disease Control and Prevention (CDC) Office of Readiness and Response (ORR) for a new five-year contract to support rapid test development during public health emergencies. The award, valued at up to $148 million (IDIQ contract 75D301-25-R-73207), will help ensure that diagnostic tools can be quickly created, validated,